| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.00058 | 1 |